![]() | |
![]() | |
| Clinical data | |
|---|---|
| Other names | 4-Propanoyl-N,N-diisopropyltryptamine; O-Propionyl-4-HO-DiPT |
| Routes of administration | Oral |
| Drug class | Serotonergic psychedelic; Hallucinogen |
| ATC code |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| Chemical and physical data | |
| Formula | C19H28N2O2 |
| Molar mass | 316.445 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
4-PrO-DiPT, also known as 4-propanoyl-N,N-diisopropyltryptamine or as O-propionyl-4-HO-DiPT, is a psychedelic drug of the tryptamine and 4-hydroxytryptamine families related to 4-PrO-DMT.1 It is the O-propionate ester of 4-HO-DiPT and has been encountered as a novel designer drug.1 The drug was first described in the scientific literature by at least 2021.1
Use and effects
Interactions
Chemistry
Analogues
Analogues of 4-PrO-DiPT include 4-HO-DiPT (iprocin), 4-AcO-DiPT (ipracetin), luvesilocin (4-GO-DiPT), 4-PrO-DMT, 4-PrO-MET, and 4-GO-DMT, among others.
Society and culture
Legal status
Canada
4-PrO-DiPT is not a controlled substance in Canada as of 2025.2
References
References
- Catalani V, Corkery JM, Guirguis A, Napoletano F, Arillotta D, Zangani C, et al. (August 2021). "Psychonauts' psychedelics: A systematic, multilingual, web-crawling exercise". European Neuropsychopharmacology. 49: 69–92. doi:10.1016/j.euroneuro.2021.03.006. PMID 33857740.
- "Controlled Drugs and Substances Act". Department of Justice Canada. Retrieved 19 January 2026.

